Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stolzenberg

Showing results (421-430 of 518) with videos related to

Pageof 52
Sort By:
Integrated Environmental Assessment and Management|September 8, 2010
Multi-criteria decision analysis of test endpoints for detecting the effects of endocrine active substances in fish full life cycle testsMark Crane, Melanie Gross, Peter Matthiessen, et al.
The Journal of Experimental Medicine|July 19, 2024
Haploinsufficiency in PTPN2 leads to early-onset systemic autoimmunity from Evans syndrome to lupusMarie Jeanpierre, Jade Cognard, Maud Tusseau, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 20, 2016
Association of Common Susceptibility Variants of Pancreatic Cancer in Higher-Risk Patients: A PACGENE StudyErica J Childs, Kari G Chaffee, Steven Gallinger, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 24, 2020
Genetic and Circulating Biomarker Data Improve Risk Prediction for Pancreatic Cancer in the General PopulationJihye Kim, Chen Yuan, Ana Babic, et al.
Clinical Spine Surgery|June 9, 2023
Preoperative Opioid Prescribers and Lumbar Fusion: Their Effect on Clinical Outcomes and Postoperative Opioid UsageMark J Lambrechts, Gregory R Toci, Tristan B Fried, et al.
Blood|January 30, 2009
FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of functionAude Magerus-Chatinet, Marie-Claude Stolzenberg, Maria S Loffredo, et al.
Cancer Research|October 27, 2016
Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic PolymorphismsAna Babic, Ying Bao, Zhi Rong Qian, et al.
American Journal of Human Genetics|September 24, 2021
A 584 bp deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion and confers risk of pancreatic cancerAshley Jermusyk, Jun Zhong, Katelyn E Connelly, et al.
American Journal of Epidemiology|June 22, 2010
Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer CancersRachael Z Stolzenberg-Solomon, Eric J Jacobs, Alan A Arslan, et al.
EMBO Molecular Medicine|October 24, 2025
In silico modeling guides identification of novel JAK1 variants associated with immune dysregulationMarie Jeanpierre, Orianne Debeaupuis, Camille Brunaud, et al.
Pageof 52

Showing results (421-430 of 518) with videos related to

Sort By:
Pageof 52
Integrated Environmental Assessment and Management|September 8, 2010
Multi-criteria decision analysis of test endpoints for detecting the effects of endocrine active substances in fish full life cycle testsMark Crane, Melanie Gross, Peter Matthiessen, et al.
The Journal of Experimental Medicine|July 19, 2024
Haploinsufficiency in PTPN2 leads to early-onset systemic autoimmunity from Evans syndrome to lupusMarie Jeanpierre, Jade Cognard, Maud Tusseau, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 20, 2016
Association of Common Susceptibility Variants of Pancreatic Cancer in Higher-Risk Patients: A PACGENE StudyErica J Childs, Kari G Chaffee, Steven Gallinger, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 24, 2020
Genetic and Circulating Biomarker Data Improve Risk Prediction for Pancreatic Cancer in the General PopulationJihye Kim, Chen Yuan, Ana Babic, et al.
Clinical Spine Surgery|June 9, 2023
Preoperative Opioid Prescribers and Lumbar Fusion: Their Effect on Clinical Outcomes and Postoperative Opioid UsageMark J Lambrechts, Gregory R Toci, Tristan B Fried, et al.
Blood|January 30, 2009
FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of functionAude Magerus-Chatinet, Marie-Claude Stolzenberg, Maria S Loffredo, et al.
Cancer Research|October 27, 2016
Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic PolymorphismsAna Babic, Ying Bao, Zhi Rong Qian, et al.
American Journal of Human Genetics|September 24, 2021
A 584 bp deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion and confers risk of pancreatic cancerAshley Jermusyk, Jun Zhong, Katelyn E Connelly, et al.
American Journal of Epidemiology|June 22, 2010
Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer CancersRachael Z Stolzenberg-Solomon, Eric J Jacobs, Alan A Arslan, et al.
EMBO Molecular Medicine|October 24, 2025
In silico modeling guides identification of novel JAK1 variants associated with immune dysregulationMarie Jeanpierre, Orianne Debeaupuis, Camille Brunaud, et al.
Pageof 52